BYSI CIK: 1677940

BeyondSpring Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
75.1
FY22:
38.5
FY23:
18.4
FY24:
28.6
FY25:
20.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.53
FY22:
7.70
FY23:
6.39
FY24:
5.74
FY25:
5.05
Total assets
Change from FY21 to FY25
millions USD
FY21:
81.6
FY22:
46.2
FY23:
24.8
FY24:
34.3
FY25:
25.9

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
15.2
FY22:
7.35
FY23:
7.96
FY24:
11.0
FY25:
13.6
(negative)
Change from FY21 to FY25
millions USD
FY21:
40.1
FY22:
41.9
FY23:
40.3
FY24:
37.6
FY25:
36.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
26.7
FY22:
−5.98
FY23:
−26.8
FY24:
−32.9
FY25:
−32.2
Total liabilities & equity
millions USD
FY21:
82.0
FY22:
–
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data sources:SEC EDGARTwelve Data